Emami Gains in Mumbai on Report It May Buy Majority Stake in Paras Pharma
Stock Chart for Emami Ltd (HMN)
Emami Ltd. gained as much as 7.3 percent in Mumbai trading after the Times of India newspaper reported the company may buy a majority stake in Ahmedabad-based Paras Pharmaceuticals Ltd. for 30 billion rupees.
Emami’s Managing Director Sushil Goenka couldn’t immediately be reached at his office telephone for comment on the report.
To contact the reporter on this story: Hemal Savai in Mumbai at email@example.com
To contact the editor responsible for this story: Tuhin Kar at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.